174 related articles for article (PubMed ID: 23851153)
1. Effect of sarpogrelate hydrochloride, a 5-hydroxytryptamine2 receptor antagonist, on allograft arteriosclerosis after aortic transplantation in rats.
Watada S; Harada H; Matsubara K; Obara H; Matsumoto K; Ando N; Kitagawa Y
Transpl Immunol; 2013 Dec; 29(1-4):162-6. PubMed ID: 23851153
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
[TBL] [Abstract][Full Text] [Related]
3. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
[TBL] [Abstract][Full Text] [Related]
4. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
[TBL] [Abstract][Full Text] [Related]
5. The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft.
Song Z; Li W; Zheng Q; Shang D; Shu X; Guan S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):303-6. PubMed ID: 17641848
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of intimal hyperplasia in murine aortic allografts by the oral administration of the transforming growth factor-beta receptor I kinase inhibitor SD-208.
Sun Y; Ye P; Wu J; Liu Z; Zhang A; Ren L; Cheng C; Huang X; Wang K; Deng P; Wu C; Yue Z; Xia J
J Heart Lung Transplant; 2014 Jun; 33(6):654-61. PubMed ID: 24685405
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
Shears LL; Kawaharada N; Tzeng E; Billiar TR; Watkins SC; Kovesdi I; Lizonova A; Pham SM
J Clin Invest; 1997 Oct; 100(8):2035-42. PubMed ID: 9329968
[TBL] [Abstract][Full Text] [Related]
8. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
Kodama A; Komori K; Kajikuri J; Itoh T
J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096
[TBL] [Abstract][Full Text] [Related]
9. Induction of indefinite survival of fully mismatched cardiac allografts and generation of regulatory cells by sarpogrelate hydrochloride.
Akiyoshi T; Zhang Q; Inoue F; Aramaki O; Hatano M; Shimazu M; Kitajima M; Shirasugi N; Niimi M
Transplantation; 2006 Oct; 82(8):1051-9. PubMed ID: 17060854
[TBL] [Abstract][Full Text] [Related]
10. Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts.
Gocht A; Distler JHW; Spriewald B; Ramsperger-Gleixner M; Weyand M; Ensminger SM; Heim C
Transpl Immunol; 2018 Aug; 49():43-53. PubMed ID: 29649585
[TBL] [Abstract][Full Text] [Related]
11. Sarpogrelate protects against high glucose-induced endothelial dysfunction and oxidative stress.
Sun YM; Su Y; Jin HB; Li J; Bi S
Int J Cardiol; 2011 Mar; 147(3):383-7. PubMed ID: 19883950
[TBL] [Abstract][Full Text] [Related]
12. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
[TBL] [Abstract][Full Text] [Related]
13. Cold ischemic injury, aortic allograft vasculopathy, and pro-inflammatory cytokine expression.
Knight RJ; Liu H; Fishman E; Reis ED
J Surg Res; 2003 Aug; 113(2):201-7. PubMed ID: 12957130
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants.
Du D; Chang S; Chen B; Zhou H; Chen ZK
Transplant Proc; 2007 Dec; 39(10):3446-8. PubMed ID: 18089403
[TBL] [Abstract][Full Text] [Related]
15. The 5-hydroxytryptamine2A receptor antagonist sarpogrelate hydrochloride inhibits acute platelet aggregation in injured endothelium.
Houkin K; Nakayama N; Nonaka T; Koyanagi I
J Int Med Res; 2006; 34(1):65-72. PubMed ID: 16604825
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of the serotonin-induced increase in intracellular calcium in rat aortic smooth muscle cells by sarpogrelate.
Saini HK; Sharma SK; Zahradka P; Kumamoto H; Takeda N; Dhalla NS
Can J Physiol Pharmacol; 2003 Nov; 81(11):1056-63. PubMed ID: 14719041
[TBL] [Abstract][Full Text] [Related]
17. Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats.
Hashizume H; Kawakami M; Yoshida M; Okada M; Enyo Y; Inomata Y
Spine (Phila Pa 1976); 2007 Feb; 32(3):315-20. PubMed ID: 17268262
[TBL] [Abstract][Full Text] [Related]
18. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
[TBL] [Abstract][Full Text] [Related]
19. Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections.
Ouyang J; Xu D; Zhang X; Qi S; Ma A; Jiang W; Chida N; Sudo Y; Tamura K; Daloze P; Chen H
Transplantation; 2005 May; 79(10):1386-92. PubMed ID: 15912108
[TBL] [Abstract][Full Text] [Related]
20. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
